Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Multi-Center Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)
Richard Lafayette, MD
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToKshama Mehta
Go Back To The Trial